AKR1B1 and neoplasm: As shown in screened eleven oxidative stress-related DEGs, AKR1B1 is necessary for tumor growth (Li et al., 2022) and was found to interact with signal transducer and activator of transcription 3 (STAT3) (Zhang et al., 2021), participating in anti-cell death processes and leading to drug resistance.